section name header

Evidence summaries

Omeprazole Versus Ranitidine in the Maintenance Therapy of Reflux Oesophagitis

Omeprazole is more effective than ranitidine in the maintenance therapy of reflux oesophagitis. Level of evidence: "A"

A systematic review 1 including 5 RCTs with a total of 1,154 subjects was abstracted in DARE.

The remission rates confirmed by endoscopy after 6 months of treatment were 82.4% for omeprazole 20 mg (95% CI 78.2 to 86.6%), 71.9% for omeprazole 10 mg (95% CI 65.5 to 78.3%), 47.5% for omeprazole weekend regime (95% CI 35.8 to 49.5%), 52.3% for ranitidine 150 mg twoce daily (95% CI 44.4 to 60.1%), and 10.6% for placebo (95% CI 5.0 to 16.3).

The remission rates after 6 months of treatment were 80.2% for omeprazole 20 mg (95% CI 73.9 to 86.4%) and 39.4% for ranitidine 300 mg daily (95% CI 31.6 to 47.2). The absolute difference in the proportion of patients in remission after 12 months was 40.8 in favour of omeprazole (NNT = 2.5).

The following decision support rules contain links to this evidence summary:

    References

    • Carlsson R, Galmiche JP, Dent J, Lundell L, Frison L. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials. Aliment Pharmacol Ther 1997 Jun;11(3):473-82. [PubMed] [DARE]

Primary/Secondary Keywords